LIA
EBS icon

LS Investment Advisors’s Emergent Biosolutions EBS Stock Holding History

LS Investment Advisors’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-4,050
Closed -$376K – 324
2021
Q1 		$376K Sell
4,050
-740
-15% -$75.8K 0.02% 472
2020
Q4 		$429K Buy
4,790
+2,201
+85% +$202K 0.02% 477
2020
Q3 		$268K Buy
2,589
+1,100
+74% +$119K 0.02% 606
2020
Q2 		$118K Buy
1,489
+11
+0.7% +$820 0.01% 934
2020
Q1 		$86K Hold
1,478
– – 0.01% 949
2019
Q4 		$80K Hold
1,478
– – ﹤0.01% 1186
2019
Q3 		$77K Hold
1,478
– – ﹤0.01% 1159
2019
Q2 		$71K Hold
1,478
– – ﹤0.01% 1195
2019
Q1 		$75K Hold
1,478
– – ﹤0.01% 1169
2018
Q4 		$88K Sell
1,478
-2,103
-59% -$136K 0.01% 1100
2018
Q3 		$236K Sell
3,581
-354
-9% -$20.7K 0.01% 772
2018
Q2 		$199K Buy
3,935
+87
+2% +$4.53K 0.01% 870
2018
Q1 		$203K Sell
3,848
-100
-3% -$4.98K 0.01% 837
2017
Q4 		$183K Buy
3,948
+2,553
+183% +$107K 0.01% 947
2017
Q3 		$56K Buy
1,395
+105
+8% +$3.8K ﹤0.01% 1312
2017
Q2 		$44K Hold
1,290
– – ﹤0.01% 1384
2017
Q1 		$37K Sell
1,290
-129
-9% -$3.93K ﹤0.01% 1413
2016
Q4 		$47K Hold
1,419
– – ﹤0.01% 1286
2016
Q3 		$45K Buy
1,419
+104
+8% +$3.02K ﹤0.01% 1257
2016
Q2 		$37K Buy
1,315
+117
+10% +$4.59K ﹤0.01% 1311
2016
Q1 		$44K Buy
1,198
+60
+5% +$2.12K ﹤0.01% 1215
2015
Q4 		$46K Hold
1,138
– – ﹤0.01% 1186
2015
Q3 		$32K Buy
1,138
+144
+14% +$4.75K ﹤0.01% 1317
2015
Q2 		$33K Buy
+994
New +$30.8K ﹤0.01% 1352

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $128B AUM 35.83% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

LS Investment Advisors's EBS Position: Q2 2021 in Review

LS Investment Advisors sold out of Emergent Biosolutions (EBS) in Q2 2021, closing a stake of 4,050 shares — an estimated $376K sold.

LS Investment Advisors first reported a position in EBS in Q2 2015 and held it in 24 quarters. The position peaked at $429K in Q4 2020. 290 funds tracked by Wall St. Rank hold EBS as of Q2 2021.

  • LS Investment Advisors reported no remaining Emergent Biosolutions position as of Q2 2021 after selling out during the quarter.
  • LS Investment Advisors sold 4,050 Emergent Biosolutions shares in Q2 2021, an estimated $376K.
  • LS Investment Advisors first reported a position in Emergent Biosolutions in Q2 2015 and held it in 24 quarters.
  • LS Investment Advisors's Emergent Biosolutions position peaked at $429K in Q4 2020.
  • 290 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2021.

Based on LS Investment Advisors's 13F filing for Q2 2021, filed 11 Aug 2021.